In TCGA, GSE26901, GSE84433, and GSE66229 datasets, we discovered that CHSY3 expression was negatively correlated with drug sensitivity of cisplatin and docetaxel, which provided us with favorable assistance in the subsequent combination therapy of GC patients (Additional file 7: Fig. S7A, B). This evidence concerns the gene CHSY3 and gastric cancer.